ANS is committed to advancing, fostering, and promoting the development and application of nuclear sciences and technologies to benefit society.
Explore the many uses for nuclear science and its impact on energy, the environment, healthcare, food, and more.
Explore membership for yourself or for your organization.
Conference Spotlight
2026 Nuclear Energy Conference & Expo (NECX)
August 24–27, 2026
Dallas, TX|Hilton Anatole
Latest Magazine Issues
Aug 2026
Jan 2026
2026
Latest Journal Issues
Nuclear Science and Engineering
October 2026
Nuclear Technology
September 2026
Fusion Science and Technology
August 2026
Latest News
LLNL, Ampera partner to develop thorium-based TRISO fuel
Lawrence Livermore National Laboratory has formed a strategic partnership with Ampera to develop the company’s nuclear fuel concept through a project named THUNDER, for Thorium Unimodal Droplet Ejection for Reactors.
The focus of THUNDER is fabricating TRISO made with kernels of thorium rather than the usual uranium. LLNL and Ampera will evaluate and optimize liquid metal–jetting technology to produce highly uniform, spherical kernels of thorium-232 for later processing into TRISO fuel.
Kenneth W. Burn
Nuclear Technology | Volume 175 | Number 1 | July 2011 | Pages 138-145
Technical Paper | Special Issue on the 16th Biennial Topical Meeting of the Radiation Protection and Shielding Division / Radiation Transport and Protection | doi.org/10.13182/NT11-A12282
Articles are hosted by Taylor and Francis Online.
The Direct Statistical Approach (DSA) was developed in the 1980s and 1990s to optimize Monte Carlo deep penetration (fixed-source) radiation transport calculations. It is based on a detailed mathematical approach to the splitting and Russian roulette problem, independent of, or dependent on, the weight of the particle track. As it relies on splitting and Russian roulette, it is of quite general application and has been employed on a wide variety of problems: reactor shielding, accelerator shielding, accelerator-driven systems, dosimetry, and nuclear medicine. The development of the DSA culminated in the inclusion of a multiresponse capability. Over the last 10 years this capability has completely supplanted the single-response version of the DSA. It is considered that the multiresponse capability represents a significant advance. Examples of its use are illustrated. The DSA is currently undergoing a substantial update. The state of the art of the new code is given.